"Kaplan-Meier Estimate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nonparametric method of compiling LIFE TABLES or survival tables. It combines calculated probabilities of survival and estimates to allow for observations occurring beyond a measurement threshold, which are assumed to occur randomly. Time intervals are defined as ending each time an event occurs and are therefore unequal. (From Last, A Dictionary of Epidemiology, 1995)
| Descriptor ID |
D053208
|
| MeSH Number(s) |
E05.318.740.998.650 N05.715.360.750.795.650 N06.850.520.830.998.650
|
| Concept/Terms |
Kaplan-Meier Estimate- Kaplan-Meier Estimate
- Estimate, Kaplan-Meier
- Kaplan-Meier Test
- Kaplan Meier Test
- Test, Kaplan-Meier
- Product-Limit Method
- Method, Product-Limit
- Methods, Product-Limit
- Product Limit Method
- Product-Limit Methods
- Kaplan-Meier Analysis
- Analysis, Kaplan-Meier
- Kaplan Meier Analysis
Kaplan-Meier Survival Curves- Kaplan-Meier Survival Curves
- Curves, Kaplan-Meier Survival
- Kaplan Meier Survival Curves
- Survival Curves, Kaplan-Meier
|
Below are MeSH descriptors whose meaning is more general than "Kaplan-Meier Estimate".
Below are MeSH descriptors whose meaning is more specific than "Kaplan-Meier Estimate".
This graph shows the total number of publications written about "Kaplan-Meier Estimate" by people in this website by year, and whether "Kaplan-Meier Estimate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 3 | 3 |
| 2007 | 0 | 13 | 13 |
| 2008 | 0 | 17 | 17 |
| 2009 | 0 | 41 | 41 |
| 2010 | 0 | 31 | 31 |
| 2011 | 0 | 50 | 50 |
| 2012 | 0 | 58 | 58 |
| 2013 | 1 | 40 | 41 |
| 2014 | 1 | 49 | 50 |
| 2015 | 0 | 50 | 50 |
| 2016 | 0 | 40 | 40 |
| 2017 | 0 | 63 | 63 |
| 2018 | 0 | 37 | 37 |
| 2019 | 0 | 38 | 38 |
| 2020 | 0 | 27 | 27 |
| 2021 | 0 | 8 | 8 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 10 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Kaplan-Meier Estimate" by people in Profiles.
-
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children. N Engl J Med. 2025 Feb 27; 392(9):875-891.
-
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors. N Engl J Med. 2025 Feb 13; 392(7):653-665.
-
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma. N Engl J Med. 2025 Jan 02; 392(1):45-55.
-
Radiomics analysis of cerebral blood flow suggests a possible link between perfusion homogeneity and poor glioblastoma multiforme prognosis. Biomed Phys Eng Express. 2024 09 09; 10(6).
-
Invasive Treatment Strategy for Older Patients with Myocardial Infarction. N Engl J Med. 2024 Nov 07; 391(18):1673-1684.
-
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma. N Engl J Med. 2024 Aug 22; 391(8):710-721.
-
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults. N Engl J Med. 2024 Jul 25; 391(4):320-333.
-
Optimizing pediatric liver transplantation: Evaluating the impact of donor age and graft type on patient survival outcome. Pediatr Transplant. 2024 Jun; 28(4):e14771.
-
Survival by first-line therapy and prognostic group among men with metastatic castration-resistant prostate cancer. Cancer Med. 2024 Jun; 13(12):e7334.
-
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia. N Engl J Med. 2024 Sep 12; 391(10):885-898.